Arthritis treatment with hypoxanthine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 24, 536 26, A61K 3152, C07H 1916

Patent

active

049314319

ABSTRACT:
The complex mixture of substances in the product made from human placentae according to the procedure described in U.S. Pat. Nos. 3,526,697 and 4,335,040 includes hypoxanthine. Hypoxanthine is effective in treating arthritis, particularly if administered intradermally at low (e.g., not more than about 0.1 mg. of hypoxanthine per does) dose. Preferably, the dose level is not more than about 0.00002 mg. active material per dose, e.g., 0.1 cc of a dilution not stronger than about 1 mg. of active material per 5,000 ml of diluent.

REFERENCES:
patent: 3526697 (1970-09-01), Livingston
patent: 4081534 (1978-03-01), Elion et al.
patent: 4309419 (1982-01-01), Wolberg et al.
patent: 4322411 (1982-03-01), Vinegar et al.
Carson et al., Proc. Natl. Acad. Sci. (U.S.A.), 79(12), 3848-52, (1982).
Glazer, Robert I., Cancer Chemotherapy, Pharmacol., 4, 227-235 (1980).
Ratech, Howard et al., (1982), Cellular Immunology, 244-251.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Arthritis treatment with hypoxanthine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arthritis treatment with hypoxanthine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arthritis treatment with hypoxanthine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-491639

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.